Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mark Meyers is active.

Publication


Featured researches published by Mark Meyers.


Mutation Research | 1996

Altered G1 checkpoint control determines adaptive survival responses to ionizing radiation.

David A. Boothman; Mark Meyers; Eric Odegaard; Meizhi Wang

Adaptive survival responses (ASRs) are observed when cells become more resistant to a high dose of a cytotoxic agent after repeated low dose exposures to that agent or another genotoxic agent. Confluent (G0/G1) human normal (GM2936B, GM2937A, AG2603, IMR-90), cancer-prone (XPV2359), and neoplastic (U1-Mel, HEp-2, HTB-152) cells were primed with repeated low doses of X-rays (ranging from 0.05-10 cGy/day for 4 days), then challenged with a high dose (290-450 cGy) on day 5. U1-Mel and HEp-2 cells showed greater than 2-fold transient survival enhancement when primed with 1-10 cGy. ASRs in U1-Mel or HEp-2 cells were blocked by cycloheximide or actinomycin D. Increases in cyclins A and D1 mRNAs were noted in primed compared to unirradiated U1-Mel and HEp-2 cells; however, only cyclin A protein levels increased. Cyclin D1 and proliferating cell nuclear antigen (PCNA) protein levels were constitutively elevated in HEp-2 and U1-Mel cells, compared to the other human normal and neoplastic cells examined, and were not altered by low or high doses of radiation. Low dose primed U1-Mel cells entered S-phase 4-6 h faster than unprimed U1-Mel cells upon low-density replating. Similar responses in terms of survival recovery, transcript and protein induction, and altered cell cycle regulation were not observed in the other human normal, cancer-prone or neoplastic cells examined. We hypothesize that only certain human cells can adapt to ionizing radiation by progressing to a point later in G1 (the A point) where DNA repair processes and radioresistance can be induced. ASRs in human cells correlated well with constitutively elevated levels of PCNA and cyclin D1, as well as inducibility of cyclin A. We propose that a protein complex composed of cyclin D1, PCNA, and possibly cyclin A may play a role in cell cycle regulation and DNA repair, which determine ASRs in human cells.


Oncogene | 2003

A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage

Mark Meyers; Arlene Hwang; Mark W. Wagner; Andrew J Bruening; Martina L. Veigl; W. David Sedwick; David A. Boothman

The phenomenon of damage tolerance, whereby cells incur DNA lesions that are nonlethal, largely ignored, but highly mutagenic, appears to play a key role in carcinogenesis. Typically, these lesions are generated by alkylation of DNA or incorporation of base analogues. This tolerance is usually a result of the loss of specific DNA repair processes, most often DNA mismatch repair (MMR). The availability of genetically matched MMR-deficient and -corrected cell systems allows dissection of the consequences of this unrepaired damage in carcinogenesis as well as the elucidation of cell cycle checkpoint responses and cell death consequences. Recent data indicate that MMR plays an important role in detecting damage caused by fluorinated pyrimidines (FPs) and represents a repair system that is probably not the primary system for detecting damage caused by these agents, but may be an important system for correcting key mutagenic lesions that could initiate carcinogenesis. In fact, clinical studies have shown that there is no benefit of FP-based adjuvant chemotherapy in colon cancer patients exhibiting microsatellite instability, a hallmark of MMR deficiency. MMR-mediated damage tolerance and futile cycle repair processes are discussed, as well as possible strategies using FPs to exploit these systems for improved anticancer therapy.


Radiation Research | 1994

Alterations in Transcription Factor Binding in Radioresistant Human Melanoma Cells after Ionizing Radiation

Walter M. Sahijdak; Chin-Rang Yang; Jeffrey S. Zuckerman; Mark Meyers; David A. Boothman

We analyzed alterations in transcription factor binding to specific, known promoter DNA consensus sequences between irradiated and unirradiated radioresistant human melanoma (U1-Mel) cells. The goal of this study was to begin to investigate which transcription factors and DNA-binding sites are responsible for the induction of specific transcripts and proteins after ionizing radiation (Boothman et al., Proc. Natl. Acad. Sci. USA 90, 7200, 1993). Transcription factor binding was observed using DNA band-shift assays and oligonucleotide competition analyses. Confluence-arrested U1-Mel cells were irradiated (4.5 Gy) and harvested at 4 h. Double-stranded oligonucleotides containing known DNA-binding consensus sites for specific transcription factors were used. Increased DNA-binding activity after ionizing radiation was noted with oligonucleotides containing the CREB, NF-kappa B and Sp1 consensus sites. Increased DNA binding activity after ionizing radiation was noted with oligonucleotides containing the CREB, NF-kappa B and Sp1 consensus sites. No changes in protein binding to AP-1, AP-2, AP-3 or CTF/NF1, GRE or Oct-1 consensus sequences were noted. X-ray activation of select transcription factors, which bind certain consensus sites in promoters, may cause specific induction or repression of gene transcription.


Cancer Research | 2001

Role of the hMLH1 DNA Mismatch Repair Protein in Fluoropyrimidine-mediated Cell Death and Cell Cycle Responses

Mark Meyers; Mark W. Wagner; Hwa-Shin Hwang; Timothy J. Kinsella; David A. Boothman


Cancer Research | 1998

Defective Expression of the DNA Mismatch Repair Protein, MLH1, Alters G2-M Cell Cycle Checkpoint Arrest following Ionizing Radiation

Thomas W. Davis; Carmell Wilson-Van Patten; Mark Meyers; Keith A. Kunugi; Scott Cuthill; Catherine A. Reznikoff; Christopher A. Garces; C. Richard Boland; Timothy J. Kinsella; Richard Fishel; David A. Boothman


Journal of Biological Chemistry | 2005

DNA Mismatch Repair-dependent Response to Fluoropyrimidine-generated Damage

Mark Meyers; Mark W. Wagner; Anthony Mazurek; Christoph Schmutte; Richard Fishel; David A. Boothman


Cancer Research | 1997

Chromosomal instability and its relationship to other end points of genomic instability

Charles L. Limoli; Mark I. Kaplan; James Corcoran; Mark Meyers; David A. Boothman; William F. Morgan


Cancer Research | 1997

Cell Cycle Regulation of the Human DNA Mismatch Repair Genes hMSH2, hMLH1, and hPMS2

Mark Meyers; Maria Theodosiou; Samir Acharya; Eric Odegaard; Teresa Wilson; Janet E. Lewis; Thomas W. Davis; Carmell Wilson-Van Patten; Richard Fishel; David A. Boothman


Environmental and Molecular Mutagenesis | 2004

Role of DNA mismatch repair in apoptotic responses to therapeutic agents

Mark Meyers; Arlene Hwang; Mark W. Wagner; David A. Boothman


Cancer Research | 1999

The Mismatch Repair Protein, hMLH1, Mediates 5-Substituted Halogenated Thymidine Analogue Cytotoxicity, DNA Incorporation, and Radiosensitization in Human Colon Cancer Cells

Suzanne E. Berry; Christopher A. Garces; Hwa Shin Hwang; Keith A. Kunugi; Mark Meyers; Thomas W. Davis; David A. Boothman; Timothy J. Kinsella

Collaboration


Dive into the Mark Meyers's collaboration.

Top Co-Authors

Avatar

David A. Boothman

University of Texas Southwestern Medical Center

View shared research outputs
Top Co-Authors

Avatar

Mark W. Wagner

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eric Odegaard

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thomas W. Davis

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Arlene Hwang

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar

Chin-Rang Yang

University of Wisconsin-Madison

View shared research outputs
Top Co-Authors

Avatar

Christopher A. Garces

University of Wisconsin-Madison

View shared research outputs
Researchain Logo
Decentralizing Knowledge